FIELD: medicine.
SUBSTANCE: children's blood serum is examined for lymphocyte count expressing CD3+; CD4+; CD8+, interferon γ (INFγ) and interleukin 4 (IL-4) on their surface. Reducing CD3+ in 1.5 sigmal interval to 51.7-59.9%; CD4+ - to 20.3-31.1%; CD8+ - to 13.8-19.6% and increasing IL-4 in CD4+ cell populations in 1.5 sigmal interval to 22.3-27.7%, IL-4 in CD8+ cells - to 27.4-31.6%, and INFγ in CD8+ cells - to 13.2-18.0% enable diagnosing acute burn toxaemia in children.
EFFECT: technique is easily reproducible, requires no expenses, providing early diagnosis of the diseases and enables diagnosing acute burn toxaemia in children.
2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF CLINICAL OUTCOME FORECAST OF ACUTE VIRAL HEPATITIS B | 2007 |
|
RU2325656C1 |
METHOD OF DIFFERENTIAL DIAGNOSIS OF INFECTIOUS MONONUCLEOSIS OF EPSHTEIN-BARR-VIRAL ETIOLOGY, ACUTE BACTERIAL TONSILLITIS AND ACUTE VIRAL HEPATITIS “B” IN ADULTS | 2017 |
|
RU2687563C2 |
METHOD FOR ONCOLOGICAL DISEASES COURSE PREDICTION | 2016 |
|
RU2622756C1 |
METHOD OF TREATING ONCOLOGICAL DISEASES | 2020 |
|
RU2741701C1 |
ATHEROSCLEROSIS MARKERS | 2005 |
|
RU2384847C2 |
METHOD FOR EVALUATION OF RISK OF PROGRESSING LATENT TUBERCULOUS INFECTION IN CHILDREN | 2009 |
|
RU2405151C2 |
METHOD FOR LIFESPAN EVALUATION IN PATIENTS WITH LOCALLY ADVANCED AND DISSEMINATED RENAL CELL CARCINOMA | 2009 |
|
RU2405150C1 |
METHOD FOR SECONDARY IMMUNODEFICIENCY DIAGNOSTICS | 2020 |
|
RU2749781C1 |
METHOD FOR PREDICTING THE FLOW AND RESULTS OF ACUTE VIRAL HEPATITIS B AND C IN TEENAGERS | 2004 |
|
RU2268470C2 |
METHOD FOR PREDICTION OF LIFE EXPECTANCY IN PATIENTS WITH METASTATIC TUMORS | 2023 |
|
RU2821659C1 |
Authors
Dates
2013-12-10—Published
2012-02-13—Filed